NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I so love all this Revimmune hype. Anybody wonder how good a deal LP with negotiate with herself?

Do have to give Rev some credit though, they actually ran a randomized trial for their IL-7 and reported the results properly.

This is the first randomized trial of atezo +/- IL-7 (CYT107) in mUC. During the trial, the FDA approval for atezo in mUC was withdrawn, which limited enrollment. However, our results show that the addition of CYT107 to atezo is safe/tolerable, with comparable toxicity profile and efficacy to monotherapy.

Not exactly a home run. Maybe they should have dug up an ECA to compare to instead?